Skip to Content

Pfizer PBC 125 (Ibrance 125 mg)

Generic Name: palbociclib

Pill with imprint Pfizer PBC 125 is Tan, Capsule-shape and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc..

Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer PBC 125

Ibrance 125 mg Pfizer PBC 125

Ibrance

Generic Name:
palbociclib
Imprint:
Pfizer PBC 125
Strength:
125 mg
Color:
Tan
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CDK 4/6 inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer Inc.
National Drug Code (NDC):
00069-0189

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide